Major League Baseball's Drug Prevention and Treatment Programs were established to prevent and end the use of Prohibited Substances by all 40- and non 40-man roster Players. The Office of the Commissioner of Baseball has concluded that the use of Prohibited Substances is potentially hazardous to a Player's health and/or may give a Player an unfair competitive advantage.
You are responsible for knowing the policies that apply to you and may be subject to consequences if you violate those Policies. Below are links to the Major and Minor League Drug Programs and other related policies and memoranda. If you have questions or concerns about any of the below information, we encourage you to reach out to your Club's medical staff or one of the contacts listed below.
Relevant Policies and Additional Information
- MLB’s Joint Drug Prevention and Treatment Program (40-Man Roster Players)
- Major League Alcohol and Marijuana Policy
- Minor League Joint Drug Prevention and Treatment Program (Domestic MiLB Players)
- Minor League Alcohol and Marijuana Policy
- Cannabis Use Policy
- 2019 Memo re: Sexual Enhancement Products
- 2022 Memo re InnoVero and DBS
- NSF Certified for Sport Lookup
- Joint MiLB Drug Program Online Education (Domestic MiLB Players)
- Minor League Offseason Contact and Location Information
- Drug Prevention and Treatment Program for Minor League Players Assigned Outside of the United States and Canada (Dominican Summer League Players)
Contact Information
For questions or concerns regarding nutritional and dietary supplements, please contact:
Tim Maxey
MLB/MLPA Joint Strength and Conditioning Coordinator
216-272-2153
[email protected]
For general program or policy questions, including medication usage, please contact:
Jon Coyles
212-931-7859
[email protected]
Lindsey Ingraham
212-931-7485
[email protected]
For more information about the Treatment Program for Substance Abuse, please contact your Club's EAP or:
Dr. Larry Westreich
212-579-7845
[email protected]